Evidence map›Paper›PMID 33354707›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Influence of Intramuscular Depot Medroxyprogesterone Acetate Initiation on Vaginal Microbiota in the Postpartum Period.

Bridget M Whitney, Sujatha Srinivasan, Kenneth Tapia, Eric Munene Muriuki, Bhavna H Chohan, Jacqueline M Wallis, Congzhou Liu, Brandon L Guthrie, R Scott McClelland, Noah G Hoffman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Bridget M WhitneyDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-3738-5704
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kenneth TapiaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Eric Munene MuriukiInstitute of Infectious and Tropical Diseases (UNITID), University of Nairobi, Nairobi, Kenya.
Bhavna H ChohanDepartment of Global Health, University of Washington, and Kenya Medical Research Institute, Nairobi, Kenya.
Jacqueline M WallisVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Congzhou LiuVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Brandon L GuthrieDepartment of Global Health and Epidemiology, University of Washington, Seattle, Washington, USA.
R Scott McClellandDepartment of Medicine, Global Health, and Epidemiology, University of Washington, Seattle, Washington, USA.
Noah G HoffmanDepartment of Medicine, University of Washington, Seattle, Washington, USA.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington, USA.
Alison C RoxbyDepartment of Medicine and Global Health, University of Washington, Seattle, Washington, USA.
University of Washington · USFred Hutch Cancer Center · USKenya Medical Research Institute · KEUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
Immune activation during pregnancy and contraception in HIV-infected Kenyan womenK23HD071788 · NICHD · UNIVERSITY OF WASHINGTON · PI ROXBY, ALISON CHRISTINA · 2012 to 2016
$648k
DMPA use and vaginal bacterial diversity among African womenR21AI129712 · NIAID · UNIVERSITY OF WASHINGTON · PI ROXBY, ALISON CHRISTINA · 2017 to 2018
$471k
NCATS NIH HHS KL2 TR002317NCATS NIH HHS TL1 TR002318NCATS NIH HHS UL1 TR002319NIAID NIH HHS P30 AI027757NIAID NIH HHS R21 AI129712NIAID NIH HHS T32 AI007140NICHD NIH HHS K23 HD071788
6 · The paper itself

Abstract

backgroundThe vaginal microbiome plays a key role in women's reproductive health. Use of exogenous hormones, such as intramuscular depot medroxyprogesterone acetate (DMPA-IM), may alter the composition of vaginal bacterial community.

methodsVaginal swab samples were collected from postpartum Kenyan women initiating DMPA-IM or nonhormonal contraception (non-HC). Bacterial vaginosis was assessed by Nugent score (Nugent-BV) and bacterial community composition was evaluated using broad-range 16S ribosomal RNA gene polymerase chain reaction with high-throughput sequencing. Changes in Nugent score, alpha diversity (Shannon diversity index), and total bacterial load between contraceptive groups from enrollment to 3 months after initiation were estimated using multivariable linear mixed effects regression.

resultsAmong 54 human immunodeficiency virus-negative women, 33 choosing DMPA-IM and 21 choosing non-HC, Nugent-BV was more common among DMPA-IM users at enrollment. At follow-up, Nugent score had decreased significantly among DMPA-IM users (change, -1.89; 95% confidence interval [CI], -3.53 to -.25; P = .02) while alpha diversity remained stable (0.03; -.24 to .30; P = .83). Conversely, Nugent score remained relatively stable among non-HC users (change, -0.73; 95% CI, -2.18 to .73; P = .33) while alpha diversity decreased (-0.34; -.67 to -.001; P = .05). The total bacterial load decreased slightly in DMPA-IM users and increased slightly among non-HC users, resulting in a significant difference in change between the contraceptive groups (difference, -0.64 log10 gene copies per swab sample; 95% CI, -1.19 to -.08; P = .02). While significant changes in Nugent score and alpha diversity were observed within contraceptive groups, changes between groups were not significantly different.

conclusionsPostpartum vaginal bacterial diversity did not change in DMPA-IM users despite a reduction in Nugent-BV, but it decreased significantly among women using non-HC. Choice of contraception may influence Lactobacillus recovery in postpartum women.

Indexed as

Contraceptive Agents, FemaleMicrobiotaFemaleHumansKenyaMedroxyprogesterone AcetatePostpartum PeriodVaginaContraceptive Agents, FemaleMedroxyprogesterone Acetatebacterial vaginosisDepot medroxyprogesterone acetatehormonal contraceptionNugent scorevaginal microbiota

Identifiers

PMID33354707
PMCPMC8204794
OpenAlexW3117751338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.